×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| HealthCare Global Enterprises | NA | NA | NA | NA | 9,675 | 261.0 |
| Jupiter Life Line Hospitals Li | 2908.23 | 432.94 | 2779.42 | 6.6 | 9352 | 48.6 |
| SHILPA MEDICARE LTD. | 1102.23 | 206.97 | 924.33 | 2.12 | 8230 | 64.0 |
HealthCare Global Enterprises Limited, with Security Code 539787, is a leading player in the Hospital industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 252.7 | 258.7 | 272.2 | 282.8 | 267.2 | 280.4 | 293.6 | 306.7 | 311.7 | 324.4 |
| Expenses | 203.1 | 218.7 | 224.7 | 232.3 | 220.5 | 225.5 | 243.7 | 248.6 | 270.2 | 265.5 |
| Operating Profit | 49.6 | 40.0 | 47.5 | 50.4 | 46.7 | 54.9 | 49.9 | 58.0 | 41.5 | 58.9 |
| OPM % | 19.64% | 15.46% | 17.46% | 17.83% | 17.49% | 19.56% | 16.99% | 18.93% | 13.31% | 18.17% |
| Other Income | 2.1 | 0.6 | 1.8 | 2.1 | 5.5 | -12.0 | 10.5 | 10.2 | -28.7 | 9.5 |
| Interest | 10.5 | 9.6 | 9.7 | 11.0 | 13.2 | 14.1 | 19.3 | 20.2 | 21.3 | 22.5 |
| Depreciation | 21.8 | 23.1 | 21.6 | 23.3 | 24.1 | 25.2 | 25.8 | 27.1 | 27.9 | 29.1 |
| Profit before tax | 19.4 | 10.9 | 18.0 | 18.3 | 15.0 | 19.7 | 15.2 | 21.0 | -1.6 | 16.9 |
| Tax % | -26.9% | -47.2% | -24.1% | -25.1% | -44.3% | -149% | 22.9% | -23.6% | 2.6% | -39.3% |
| Net Profit | 14.2 | 4.2 | 13.7 | 13.7 | 8.3 | -1.8 | 11.7 | 16.0 | -37.3 | 10.2 |
| EPS in Rs | 1.01 | 0.3 | 0.98 | 0.98 | 0.59 | -0.13 | 0.83 | 1.14 | -2.64 | 0 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 424.7 | 441.7 | 460.7 | 486.9 | 469.9 | 494.6 | 525.6 | 553.5 | 557.6 | 585.2 |
| Expenses | 349.2 | 365.4 | 386.4 | 402.3 | 391.3 | 402.6 | 434.7 | 451.3 | 470.2 | 479.5 |
| Operating Profit | 75.5 | 76.3 | 74.3 | 84.6 | 78.6 | 92.0 | 90.9 | 102.2 | 87.4 | 105.7 |
| OPM % | 17.78% | 17.28% | 16.13% | 17.38% | 16.73% | 18.61% | 17.3% | 18.47% | 15.67% | 18.07% |
| Other Income | 3.7 | 4.7 | 2.4 | 3.4 | 6.1 | 9.0 | 8.8 | 11.1 | 5.7 | 10.2 |
| Interest | 27.1 | 25.6 | 25.6 | 26.9 | 29.5 | 26.8 | 33.7 | 36.0 | 40.7 | 44.2 |
| Depreciation | 40.8 | 42.2 | 41.0 | 43.2 | 44.2 | 46.0 | 47.0 | 49.7 | 56.5 | 58.1 |
| Profit before tax | 11.3 | 13.1 | 10.2 | 17.9 | 11.1 | 24.3 | 19.0 | 27.7 | -4.2 | 13.7 |
| Tax % | -62.8% | -56.9% | -67.6% | -39.8% | -68.9% | -16.9% | -28.2% | 25.2% | -263.1% | -49.6% |
| Net Profit | 4.2 | 5.7 | 3.7 | 10.8 | 3.4 | 23.5 | 13.6 | 20.7 | 7.8 | 6.8 |
| EPS in Rs | 0.54 | 0.6 | 0.54 | 0.97 | 0.41 | 1.51 | 0.86 | 1.28 | 0.49 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 11% |
| 3 Years: | 22% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 42% |
| 3 Years: | 46% |
| TTM: | -25% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 42% |
| 3 Years: | 29% |
| 1 Year: | 66% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 14% |
| 3 Years: | 24% |
| TTM: | 15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 29% |
| 3 Years: | 33% |
| TTM: | 137% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 42% |
| 3 Years: | 29% |
| 1 Year: | 66% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|